National Cancer Institute; Notice of Closed Meeting, 14806 [E9-7312]
Download as PDF
14806
Federal Register / Vol. 74, No. 61 / Wednesday, April 1, 2009 / Notices
Date: April 30–May 1, 2009.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Gail J. Bryant, MD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8107,
MSC 8328, Bethesda, MD 20892–8328, (301)
402–0801, gb30t@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7308 Filed 3–31–09; 8:45 am]
Date: April 9–10, 2009.
Time: 1 p.m.–5 p.m.
Agenda: To evaluate the Rapid Access to
Intervention Development Portfolio.
Place: National Institutes of Health,
Executive Plaza North, Conference Room H,
6130 Executive Boulevard, Rockville, MD
20852.
Contact Person: Phyllis G. Bryant,
Executive Secretary, Program Analyst,
Developmental Therapeutics Program,
National Cancer Institute, NIH, 6130
Executive Boulevard, Rm. 8022, Bethesda,
MD 20892, (301) 496–8720, pb45q@nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7312 Filed 3–31–09; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The purpose of this meeting
is to evaluate requests for preclinical
development resources for potential
new therapeutics for the treatment of
cancer. The outcome of the evaluation
will be a decision whether NCI should
support request(s) and make available
contract resources for development of
the potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Rapid
Access to Intervention Development.
VerDate Nov<24>2008
17:46 Mar 31, 2009
Jkt 217001
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Basic HIV Vaccine
Discovery Research (R01).
Date: April 29–May 1, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Sujata Vijh, PhD, Scientific
Review Officer, Scientific Review Program,
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–594–
0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7304 Filed 3–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NINDS Conference Grant
Review Panel.
Date: April 9, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, 3201, Rockville, MD 20852.
(Virtual Meeting).
Contact Person: Alan L. Willard, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20852–
9529. (301) 496–5390.
willarda@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
E:\FR\FM\01APN1.SGM
01APN1
Agencies
[Federal Register Volume 74, Number 61 (Wednesday, April 1, 2009)]
[Notices]
[Page 14806]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-7312]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5
U.S.C., as amended. The purpose of this meeting is to evaluate requests
for preclinical development resources for potential new therapeutics
for the treatment of cancer. The outcome of the evaluation will be a
decision whether NCI should support request(s) and make available
contract resources for development of the potential therapeutic to
improve the treatment of various forms of cancer. The research
proposals and the discussions could disclose confidential trade secrets
or commercial property such as patentable material and personal
information concerning individuals associated with the proposed
research projects, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Rapid Access to Intervention Development.
Date: April 9-10, 2009.
Time: 1 p.m.-5 p.m.
Agenda: To evaluate the Rapid Access to Intervention Development
Portfolio.
Place: National Institutes of Health, Executive Plaza North,
Conference Room H, 6130 Executive Boulevard, Rockville, MD 20852.
Contact Person: Phyllis G. Bryant, Executive Secretary, Program
Analyst, Developmental Therapeutics Program, National Cancer
Institute, NIH, 6130 Executive Boulevard, Rm. 8022, Bethesda, MD
20892, (301) 496-8720, pb45q@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to scheduling conflicts.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7312 Filed 3-31-09; 8:45 am]
BILLING CODE 4140-01-P